AI-generated summary
The authors report a long-term follow-up of 94 head and neck cancer patients who received chemoradiation with or without low-level laser therapy to prevent oral mucositis. Patients receiving laser therapy had a higher complete response rate and higher progression-free survival, with a trend toward better overall survival that was not statistically significant. The authors state that larger studies are needed to confirm these findings.
- Participants
- 94
- Who or what was studied
- Patients with oropharynx, nasopharynx, or hypopharynx cancer receiving conventional radiotherapy plus cisplatin
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The authors state that further studies with a larger sample are necessary to confirm the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660nm
- Energy density (fluence)
- 4J/cm2
- Power
- 100mW
- Total energy
- 1J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.